# Phase 5B decision

**BLOCKED_PENDING_HUMAN_REVIEW**

No reviewer has graded the existing 40-query pool or the new ten-query diagnostic pilot. The available proxy evidence does not justify choosing a corpus, retrieval, candidate-selection or ranking intervention as the single Phase 5C improvement. Preserve the current production pipeline.

Minimum useful next action: independently grade `P01`–`P10` in the blinded CSV using only the supplied pre-cutoff publication evidence. Each candidate has two reviewer slots. Keep private stratum/rank/proxy mappings hidden from reviewers. Record an explicit reviewer ID; leave insufficient or ambiguous evidence blank with a note. Once reviews exist, run the evaluation command in the coverage report and inspect judged coverage, reviewer agreement, disagreement with proxy labels, and the rate of grade ≥2 in each sampled stratum. The pilot is opportunity-enriched and cannot estimate overall prevalence or a system-level gain.

If the pilot yields actionable, well-supported cases, pre-register exactly one bounded intervention against a common judged pool, then evaluate it on independent queries and a separate untouched temporal test. If relevant evidence is too sparse or inconsistent, retain the current pipeline and stop. No model training, production change, full graph rebuild or further retrieval expansion was performed in Phase 5B.
